↗8 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$91KSold on the market
1Companies
Oct 20, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 202616:56 | Oct 16, 2026 | FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | S · Sell10b5-1 | $12.84 | −1,635 | 8,617 | -16% | −$21K | ||
| Oct 20, 202616:56 | Oct 16, 2026 | FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | M · Exercise10b5-1 | $4.14 | +1,635 | 10,252 | +19% | $7K | ||
| Sep 22, 202618:43 | Sep 16, 2026 | FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | S · Sell10b5-1Late 6d | $13.65 | −1,635 | 8,617 | -16% | −$22K | ||
| Sep 22, 202618:43 | Sep 16, 2026 | FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | M · Exercise10b5-1Late 6d | $4.14 | +1,635 | 10,252 | +19% | $7K | ||
| Sep 3, 202618:55 | Sep 1, 2026 | FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | S · Sell10b5-1 | $14.00 | −584 | 8,617 | -6% | −$8K | ||
| Sep 3, 202618:55 | Sep 1, 2026 | FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | M · Exercise10b5-1 | $6.49 | +584 | 9,201 | +7% | $4K | ||
| Aug 17, 202617:34 | Aug 17, 2026from Aug 13, 2026 | FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | S · Sell10b5-1 | $12.10 | −3,270 | 8,617 | -28% | −$40K | ||
| Aug 17, 202617:34 | Aug 17, 2026from Aug 13, 2026 | FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | M · Exercise10b5-1 | $4.14 | +3,270 | 10,252 | +47% | $14K |